Home   >  
Others Pathway
Vitamin D Related

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Vitamin D Related

Chemical Structure Cat. No. Product Name CAS No.
Seocalcitol Chemical Structure
BCP38354 Seocalcitol 134404-52-7
Seocalcitol is a vitamin D analog, binds vitamin D receptor protein from human osteosarcoma MG-63 cells with Kd of 0.27 nM.
Elocalcitol Chemical Structure
BCP38256 Elocalcitol 199798-84-0
Elocalcitol is a calcitriol analog for inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia.
Inecalcitol Chemical Structure
BCP23832 Inecalcitol 163217-09-2
Inecalcitol is an inhibitor of the growth of human breast cancer cells in vitro and in vivo.
5,6-trans-Vitamin D3 Chemical Structure
BCP38025 5,6-trans-Vitamin D3 22350-41-0
5,6-trans-Vitamin D3 is an isomer of vitamin D3.
TEI-9647 Chemical Structure
BCP37861 TEI-9647 173388-20-0
TEI-9647 is a vitamin D antagonist which inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
ZK-15922 Chemical Structure
BCP37860 ZK-15922 156965-15-0
ZK159222 is a vitamin D receptor antagonist.
Pyridoxamine Chemical Structure
BCP36336 Pyridoxamine 85-87-0
Pyridoxylamine is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions.
Pyridoxal phosphate Chemical Structure
BCP34576 Pyridoxal phosphate 54-47-7
Pyridoxal Phosphate is the active form of vitamin B6 and a coenzyme for many pyridoxal phosphate (PLP)-dependent enzymes.
Cholecalciferol Chemical Structure
BCP34143 Cholecalciferol 67-97-0
Cholecalciferol(Vitamin D3) is a naturally occuring form of vitamin D; Reported that upon metabolic activation, Cholecalciferol induces cell differentiation and prevents proliferation of cancer cells.
Lexacalcitol Chemical Structure
BCP29394 Lexacalcitol 131875-08-6
Lexacalcitol is a 20-epi-vitamin D3 analog. it is of potential interest in the treatment of psoriasis and prevents type I diabetes in preclinical investigation.
123下一頁末頁共 34 條記錄 1 / 4 頁